Key result
Selective pulmonary vasodilation may pose potential hazards in elderly patients with pulmonary hypertension secondary to heart failure with preserved ejection fraction.
Case Report (n=1)
Highlights the importance of recognizing HFpEF as a cause of pulmonary hypertension in the elderly and cautions against the use of selective pulmonary vasodilators in this population.
Cautions against selective pulmonary vasodilators in elderly HFpEF-PH; case report leaves open need for prospective validation.
Heart failure with preserved ejection fraction (HFpEF) is a common but under-recognized cause of pulmonary hypertension (PH), particularly among the elderly. While elevated pulmonary artery pressures are clearly associated with increased mortality in HFpEF, it remains unknown whether or how pulmonary vascular disease in HFpEF should be treated. This case emphasizes the importance of maintaining a high index of suspicion for HFpEF in elderly patients presenting with PH and illustrates potential hazards associated with selective pulmonary vasodilation in this growing population.
No takes yet. Share an insight, caveat, or question.
Boilson et al. (2009) conducted a case report in Heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) (n=1). Selective pulmonary vasodilation was evaluated. Selective pulmonary vasodilation may pose potential hazards in elderly patients with pulmonary hypertension secondary to heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: